KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) FCF Margin (2018 - 2025)

Moderna (MRNA) has disclosed FCF Margin for 8 consecutive years, with 131.42% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 10005.0% to 131.42% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 106.22% through Dec 2025, up 2165.0% year-over-year, with the annual reading at 106.22% for FY2025, 1908.0% up from the prior year.
  • FCF Margin for Q4 2025 was 131.42% at Moderna, up from 93.8% in the prior quarter.
  • The five-year high for FCF Margin was 152.3% in Q1 2021, with the low at 1006.48% in Q1 2025.
  • Average FCF Margin over 5 years is 154.01%, with a median of 3.25% recorded in 2022.
  • The sharpest move saw FCF Margin skyrocketed 155230bps in 2021, then plummeted -57485bps in 2024.
  • Over 5 years, FCF Margin stood at 45.28% in 2021, then tumbled by -32bps to 30.88% in 2022, then decreased by -26bps to 22.77% in 2023, then surged by 38bps to 31.37% in 2024, then surged by 319bps to 131.42% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 131.42%, 93.8%, and 645.07% for Q4 2025, Q3 2025, and Q2 2025 respectively.